Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-20EMA Authorised: Vimpat (lacosamide) — UCB Pharma SA
Authorised status for Vimpat (lacosamide) by EMA under UCB Pharma SA for epilepsy.
-
EMA approval · 2026-08-11EMA Authorised: Zebinix (eslicarbazepine acetate) — BIAL - Portela & Ca, S.A.
Zebinix (eslicarbazepine acetate) has been authorised in the European Union for epilepsy by BIAL.
-
FDA approval · 2026-08-10FDA Approved: BRIVARACETAM — Original Application (Aurobindo Pharma Limited)
FDA approval overview for the generic anticonvulsant brivaracetam marketed by Aurobindo Pharma Limited.
-
EMA approval · 2026-08-07EMA Authorised: Lacosamide Adroiq (lacosamide) — Extrovis EU Ltd
EMA has authorised Lacosamide Adroiq (lacosamide) for epilepsy with Extrovis EU Ltd as manufacturer.
-
CLINICAL_TRIALS trial_result · 2026-07-31Clinical Trial Results: Safety and Efficacy of tPBM for Epileptiform Activity in Autism [Phase 2]
Phase 2 trial evaluating safety and efficacy of transcranial photobiomodulation for epileptiform activity in autism; results completed with …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2026-07-01EMA Authorised: Ontozry (cenobamate) — Angelini Pharma S.p.A
EMA has authorised Ontozry (cenobamate) for epilepsy, with Angelini Pharma S.p.A as the marketing authorization holder.
-
CLINICAL_TRIALS trial_result · 2026-06-09Clinical Trial Results: Pharmacokinetics Study of Oral 2-Deoxy-D-Glucose (2DG) in Subjects With a Confirmed Diagnosis of Epilepsy [Phase 2]
Phase 2 pharmacokinetics study of oral 2-Deoxy-D-Glucose (2DG) in adults with epilepsy was completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Safety and Efficacy of tPBM for Epileptiform Activity in Autism [Phase 2]
Phase 2 trial evaluating safety and efficacy of transcranial photobiomodulation for epileptiform activity in autism has completed. The updat…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Study to Test the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures [Phase 3]
This Phase 3 trial is evaluating the safety and tolerability of Staccato Alprazolam in participants 12 years and older with stereotypical pr…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Tumor Related Epilepsy
NINDS-sponsored clinical trial exploring tumor-related epilepsy is currently recruiting, focusing on seizures associated with brain tumors.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy [Phase 1]
A Phase 1 clinical trial sponsored by NINDS is evaluating blood-brain barrier breakdown using manganese-enhanced MRI in people with drug-res…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Medtronic Deep Brain Stimulation (DBS) Therapy for Epilepsy Post-Approval Study (EPAS) [NA]
Update indicates Medtronic's Deep Brain Stimulation therapy for epilepsy (EPAS) post-approval study has been terminated.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: PET/MRI/EEG Imaging Study in Epilepsy
A Massachusetts General Hospital study is evaluating PET/MRI/EEG imaging in epilepsy and is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders
Recruitment is ongoing for a study that investigates transgenerational metabolic-immune biomarkers in autism spectrum disorder and related m…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: An Examination of Whether Infrared Light Therapy Can Reduce Stress in People With Epilepsy [NA]
A ClinicalTrials.gov update shows a study testing infrared light therapy to reduce stress in individuals with epilepsy, currently in recruit…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Evaluation of the FYNA Research OPM MEG Device for Locating Epileptic Foci as Part of Pre-surgical Assessment of Epilepsy [NA]
Clinical trial update for evaluating the FYNA Research OPM MEG device to locate epileptic foci during pre-surgical assessment; the study is …
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: PREDiction of Different Variants of Sleep Stages for the Diagnosis Support of Chronic Insomnia and Epilepsy
This clinical trial is investigating predicting sleep stage variants to support diagnosis of chronic insomnia and epilepsy, and is currently…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Understanding Ketamine's Dissociative Effects (KD Study) [Phase 1]
A Phase 1 clinical trial at Stanford University is recruiting to study the dissociative effects of ketamine in epilepsy patients.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Phenotypic Exploration During Sensory Stimulation in an Acoustic Chamber
Clinical trial update noting recruitment for a study investigating phenotypic responses during sensory stimulation in an acoustic chamber in…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Exploratory Study of UX-GIP001 Cell Therapy in Adult Patients With Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (MTLE) [EARLY_Phase 1]
An early-phase exploratory study investigating UX-GIP001 cell therapy for adults with drug-resistant unilateral mesial temporal lobe epileps…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Causal Role of Top-Down Theta Oscillations in Prioritization [NA]
This clinical trial update describes a study investigating the causal role of top-down theta oscillations in prioritization; it is currently…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Post-Market Real-World Evidence Registry for the NeuroOne OneRF® Ablation System for Epilepsy
A post-market real-world evidence registry is planned to evaluate the NeuroOne OneRF ablation system for epilepsy; the study is not yet recr…
-
FDA approval · 2026-04-21FDA Approved: LEVETIRACETAM — Supplemental Application (Patrin Pharma, Inc.)
The FDA approved a supplemental application for levetiracetam from Patrin Pharma, Inc., marking an approved change to the product's labeling…
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant Epilepsy [Phase 2]
Clinical trial update indicates a Phase 2 safety and tolerability study of SPN-817 in adults with treatment-resistant epilepsy is currently …
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: The Clinical Utility of BioEP in Diagnostic Decision Making in Epilepsy [NA]
Neuronostics Ltd is evaluating the BioEP diagnostic tool for guiding epilepsy diagnostic decisions, and the trial is currently recruiting.